Pfizer-BioNTech booster doses may be approved by the Food and Drug Administration. The COVID-19 vaccination was made available to all adults in the United States this week, drastically expanding access to new vaccines for tens of millions of Americans, according to The New York Times. Pfizer application for universal booster authorization to individuals 18 and older will be reviewed by the Centers for Disease Control and Prevention’s panel of independent experts on Friday.
Concerns over the spread of the coronavirus prompted the corporation to seek permission from regulators earlier this month, especially as the country prepared for the busy holiday season. According to the Times, if the CDC and FDA approve the expanded booster programme, all U.S. adults could receive booster doses as soon as this weekend, as long as their second vaccination was at least six months ago. About 30.7 million people have received a booster shot, and 195.4 million Americans have received the entire COVID-19 vaccine.
Gov. Phil Murphy (D) of New Jersey advised folks to “simply get a booster,” saying the state wanted “as many people boosted as possible” as the holidays approached. President Joe Biden had wanted to announce a large booster programme in September, but the proposal was cut reduced after federal experts and agency officials expressed worries that there wasn’t enough data at the time. They cited studies showing that all three coronavirus vaccinations approved for use in the United States are still effective in preventing serious disease and death. According to studies, the vaccinations’ potency begins to decline roughly six months following the second injection of both the Pfizer and Moderna vaccines.